244: Why AI Still Hasn't Revolutionized Drug Discovery (Yet) | Thibault Geoui, PhD

Send us Fan Mail If AI is already being used across the drug development pipeline, why hasn’t its impact matched the investment? AI can help researchers review scientific literature, predict protein structures, prioritize molecules, assess toxicity, support clinical trials, and monitor adverse events. But access to better tools doesn’t automatically create better drugs. In this episode, I speak with Thibault Geoui, Science CDO and host of the Tech & Drugs Podcast, about where AI is making...